INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 114 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $21,970,000 | -16.4% | 3,165,665 | +12.3% | 0.00% | -20.0% |
| Q3 2016 | $26,277,000 | +6.4% | 2,819,426 | +5.5% | 0.01% | 0.0% |
| Q2 2016 | $24,697,000 | +1.1% | 2,672,880 | -4.7% | 0.01% | -16.7% |
| Q1 2016 | $24,429,000 | +31.4% | 2,804,668 | +1.4% | 0.01% | +50.0% |
| Q4 2015 | $18,594,000 | +11.3% | 2,766,936 | -4.2% | 0.00% | 0.0% |
| Q3 2015 | $16,703,000 | -27.3% | 2,889,734 | +2.7% | 0.00% | -33.3% |
| Q2 2015 | $22,969,000 | +15.5% | 2,814,851 | +15.5% | 0.01% | +20.0% |
| Q1 2015 | $19,891,000 | -9.1% | 2,437,604 | +2.3% | 0.01% | 0.0% |
| Q4 2014 | $21,881,000 | +54.7% | 2,383,526 | +66.0% | 0.01% | +25.0% |
| Q3 2014 | $14,140,000 | -11.8% | 1,435,523 | -3.2% | 0.00% | -20.0% |
| Q2 2014 | $16,023,000 | – | 1,482,271 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 200,000 | $998,000 | 0.36% |
| Green Alpha Advisors, LLC | 72,647 | $363,000 | 0.24% |
| Skaana Management L.P. | 227,851 | $1,137,000 | 0.18% |
| SEVEN EIGHT CAPITAL, LP | 196,351 | $980,000 | 0.18% |
| Defender Capital, LLC. | 103,038 | $514,000 | 0.16% |
| Skaana Management L.P. | 206,300 | $1,029,000 | 0.16% |
| WASATCH ADVISORS LP | 4,926,125 | $24,581,000 | 0.10% |
| Parametrica Management Ltd | 16,183 | $81,000 | 0.08% |
| Cedar Brook Financial Partners, LLC | 54,500 | $272,000 | 0.07% |
| Hennion & Walsh Asset Management, Inc. | 274,703 | $1,371,000 | 0.07% |